In Brief: Zer Hitech, Ltd.
This article was originally published in The Gray Sheet
Executive Summary
Zer Hitech, Ltd.: Jerusalem-based company gives Calcol the go-ahead in Dec. 9 letter of intent to form within six months a new company that would have rights to manufacture and distribute Zer Hitech's portfolio of in vitro diagnostic tests, which are either marketed outside the U.S. or are under development. Calcol would be responsible for FDA approval of the IVD kits, which test for pregnancy, ovulation, menopause and HIV I/II. Test kits for hepatitis B and drugs of abuse are still under development. If Zer Hitech forms partnerships with other firms for its pregnancy, ovulation and menopause tests, Calcol would lose rights to those products...